Transition of Care in Type 1 Diabetes Mellitus
Launched by NORTHERN SYDNEY AND CENTRAL COAST AREA HEALTH SERVICE · Oct 30, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
There are significant limitations in the literature relating to transition from paediatric to adult healthcare.
In healthcare, transition describes the purposeful process of planning and moving from paediatric to adult services and usually occurs in adolescence (in itself a time of rapid physical, cognitive and psychosocial growth between childhood and adulthood). The available evidence within the literature to guide this process of transition is often limited and additional evidence to guide clinical practice is required. Although reports within the literature vary, it is known that up to...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adolescents who have an existing diagnosis of type 1 diabetes mellitus and who underwent (in 2020 to 8th June, 2023) or who are undergoing (from 9th June, 2023 and subsequent cohorts) transition from paediatric care to adult health care at Royal North Shore Hospital and Mona Vale Community Health Centre. Adolescents with type 1 diabetes will be 16 years or older
- • A family member or caregiver of the participant of the adolescent patient with type 1 diabetes mellitus
- • A staff member who is a member of the patient's treating diabetes team within the paediatric diabetes service (first study visit and second study visit) and young adult diabetes service (third study visit)
- Exclusion Criteria:
- • There are no specific exclusion criteria
About Northern Sydney And Central Coast Area Health Service
Northern Sydney and Central Coast Area Health Service is a leading healthcare organization dedicated to delivering high-quality medical services and advancing clinical research in the Northern Sydney and Central Coast regions of New South Wales, Australia. As a prominent sponsor of clinical trials, the organization focuses on innovative research initiatives that aim to improve patient outcomes and enhance healthcare practices. By collaborating with healthcare professionals, researchers, and community stakeholders, the Area Health Service fosters a commitment to evidence-based medicine and strives to contribute to the global body of medical knowledge through rigorous and ethical trial conduct.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sydney, New South Wales, Australia
Patients applied
Trial Officials
Shihab Hameed, MBBS
Principal Investigator
Royal North Shore Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported